Surveillance for hepatocellular carcinoma...a hotly debated issue.
The question of screening for hepatocellular carcinoma and particularly the surveillance of patients with cirrhosis remains hotly debated. Indeed, even if well defined groups at risk and accurate tools of early diagnosis exist, the impact of screening on the survival improvement has not yet been completely demonstrated. Moreover, the prevalence of hepatocarcinoma and the aetiologies of cirrhosis differ according to regions resulting in recommendations that should be adapted to each country. The purpose of this review is to summarise the data of the literature and to provide adapted recommendation for our country.
Henrion
J
J
Hôpital de Jolimont, Department of Internal Medicine, Division of Hepato-Gastroenterology, Haine-Saint-Paul, Belgium.
D001530:Belgium / Q000453:epidemiology; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality; D006801:Humans; D008103:Liver Cirrhosis / Q000453:epidemiology; D008113:Liver Neoplasms / Q000175:diagnosis / Q000453:epidemiology* / Q000401:mortality; D008403:Mass Screening; D011159:Population Surveillance